How long do cognitive and memory dysfunctions persist after SARS-CoV-2 infection?

FHS
March 4, 2024
11:12 am

Whether cognitive deficits can be measured after severe acute respiratory syndrome (SARS-CoV-2) infection.

Viking Therapeutics obesity drug hits target in key study, raising hopes for a competitor to existing medicines

An obesity medication from Viking Therapeutics succeeded in a Phase 2 clinical study, the company said Tuesday, helping patients lose up to nearly 15% of

February 27, 2024

Exclusive: Dupixent in a pill? Startup Insamo will try to turn blockbuster biologics into orals

A new biotech startup launched Wednesday to advance a “Goldilocks” therapeutic modality that could turn some of the industry’s most lucrative drugs into pills. Berkeley,

February 22, 2024

Travere signs $120m licensing deal with Renalys for sparsentan in Asia

Share this article Sparsentan received accelerated approval by the US Food and Drug Administration (FDA) to reduce proteinuria in adults with primary IgA nephropathy. Credit:

January 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.